1	Study	_	_	NN	_	_	_	_	_
2	suggests	_	_	VBZ	_	_	_	_	_
3	'	_	_	``	_	_	_	_	_
4	sleeping	_	_	VBG	_	_	_	_	_
5	sickness	_	_	NN	_	_	_	_	_
6	'	_	_	''	_	_	_	_	_
7	parasite	_	_	NN	_	_	_	_	_
8	mutated	_	_	VBN	_	_	_	_	_
9	to	_	_	TO	_	_	_	_	_
10	evade	_	_	VB	_	_	_	_	_
11	immune	_	_	JJ	_	_	_	_	_
12	system	_	_	NN	_	_	_	_	_
13	defences	_	_	NNS	_	_	_	_	_


1	Wednesday	_	_	NNP	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	September	_	_	NNP	_	_	_	_	_
4	1	_	_	CD	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	2010	_	_	CD	_	_	_	_	_


1	File	_	_	NN	_	_	_	_	_
2	photo	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	trypanosoma	_	_	NN	_	_	_	_	_
5	brucei	_	_	NNP	_	_	_	_	_


1	Research	_	_	NN	_	_	_	_	_
2	teams	_	_	NNS	_	_	_	_	_
3	from	_	_	IN	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	universities	_	_	NNS	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	Georgia	_	_	NNP	_	_	_	_	_
8	and	_	_	CC	_	_	_	_	_
9	Glasgow	_	_	NNP	_	_	_	_	_
10	discovered	_	_	VBD	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	mechanism	_	_	NN	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	Trypanosome	_	_	NNP	_	_	_	_	_
15	parasite	_	_	NN	_	_	_	_	_
16	evolved	_	_	VBD	_	_	_	_	_
17	for	_	_	IN	_	_	_	_	_
18	"	_	_	``	_	_	_	_	_
19	sleeping	_	_	VBG	_	_	_	_	_
20	sickness	_	_	NN	_	_	_	_	_
21	"	_	_	''	_	_	_	_	_
22	disease	_	_	NN	_	_	_	_	_
23	to	_	_	TO	_	_	_	_	_
24	circumvent	_	_	VB	_	_	_	_	_
25	the	_	_	DT	_	_	_	_	_
26	human	_	_	JJ	_	_	_	_	_
27	immune	_	_	JJ	_	_	_	_	_
28	system	_	_	NN	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_


1	Their	_	_	PRP$	_	_	_	_	_
2	study	_	_	NN	_	_	_	_	_
3	follows	_	_	VBZ	_	_	_	_	_
4	a	_	_	DT	_	_	_	_	_
5	recent	_	_	JJ	_	_	_	_	_
6	African	_	_	JJ	_	_	_	_	_
7	outbreak	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	disease	_	_	NN	_	_	_	_	_
11	this	_	_	DT	_	_	_	_	_
12	parasite	_	_	NN	_	_	_	_	_
13	causes	_	_	VBZ	_	_	_	_	_
14	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	discovery	_	_	NN	_	_	_	_	_
3	is	_	_	VBZ	_	_	_	_	_
4	expected	_	_	VBN	_	_	_	_	_
5	to	_	_	TO	_	_	_	_	_
6	help	_	_	VB	_	_	_	_	_
7	develop	_	_	VB	_	_	_	_	_
8	a	_	_	DT	_	_	_	_	_
9	cure	_	_	NN	_	_	_	_	_
10	preventing	_	_	VBG	_	_	_	_	_
11	future	_	_	JJ	_	_	_	_	_
12	deaths	_	_	NNS	_	_	_	_	_
13	.	_	_	.	_	_	_	_	_


1	A	_	_	DT	_	_	_	_	_
2	tsetse	_	_	NN	_	_	_	_	_
3	fly	_	_	NN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	generally	_	_	RB	_	_	_	_	_
6	responsible	_	_	JJ	_	_	_	_	_
7	for	_	_	IN	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	spread	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	condition	_	_	NN	_	_	_	_	_
13	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	1998	_	_	CD	_	_	_	_	_
3	â€“	_	_	TO	_	_	_	_	_
4	2001	_	_	CD	_	_	_	_	_
5	sleeping	_	_	VBG	_	_	_	_	_
6	sickness	_	_	NN	_	_	_	_	_
7	epidemics	_	_	NNS	_	_	_	_	_
8	in	_	_	IN	_	_	_	_	_
9	South	_	_	NNP	_	_	_	_	_
10	Sudan	_	_	NNP	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	Angola	_	_	NNP	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	Democratic	_	_	NNP	_	_	_	_	_
15	Republic	_	_	NNP	_	_	_	_	_
16	of	_	_	IN	_	_	_	_	_
17	Congo	_	_	NNP	_	_	_	_	_
18	,	_	_	,	_	_	_	_	_
19	and	_	_	CC	_	_	_	_	_
20	Uganda	_	_	NNP	_	_	_	_	_
21	caused	_	_	VBD	_	_	_	_	_
22	tens	_	_	NNS	_	_	_	_	_
23	of	_	_	IN	_	_	_	_	_
24	thousands	_	_	NNS	_	_	_	_	_
25	of	_	_	IN	_	_	_	_	_
26	deaths	_	_	NNS	_	_	_	_	_
27	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	parasites	_	_	NNS	_	_	_	_	_
3	are	_	_	VBP	_	_	_	_	_
4	spread	_	_	VBN	_	_	_	_	_
5	by	_	_	IN	_	_	_	_	_
6	tsetse	_	_	NN	_	_	_	_	_
7	flies	_	_	NNS	_	_	_	_	_
8	.	_	_	.	_	_	_	_	_


1	It	_	_	PRP	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	considered	_	_	VBN	_	_	_	_	_
4	one	_	_	CD	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	worst	_	_	JJS	_	_	_	_	_
8	epidemics	_	_	NNS	_	_	_	_	_
9	in	_	_	IN	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	last	_	_	JJ	_	_	_	_	_
12	five	_	_	CD	_	_	_	_	_
13	decades	_	_	NNS	_	_	_	_	_
14	.	_	_	.	_	_	_	_	_


1	As	_	_	IN	_	_	_	_	_
2	WHO	_	_	NNP	_	_	_	_	_
3	reported	_	_	VBD	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	subsequent	_	_	JJ	_	_	_	_	_
6	recent	_	_	JJ	_	_	_	_	_
7	introduction	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	population	_	_	NN	_	_	_	_	_
10	screening	_	_	NN	_	_	_	_	_
11	in	_	_	IN	_	_	_	_	_
12	rural	_	_	JJ	_	_	_	_	_
13	areas	_	_	NNS	_	_	_	_	_
14	and	_	_	CC	_	_	_	_	_
15	distribution	_	_	NN	_	_	_	_	_
16	of	_	_	IN	_	_	_	_	_
17	more	_	_	RBR	_	_	_	_	_
18	effective	_	_	JJ	_	_	_	_	_
19	drugs	_	_	NNS	_	_	_	_	_
20	had	_	_	VBD	_	_	_	_	_
21	potentially	_	_	RB	_	_	_	_	_
22	reduced	_	_	VBN	_	_	_	_	_
23	the	_	_	DT	_	_	_	_	_
24	number	_	_	NN	_	_	_	_	_
25	of	_	_	IN	_	_	_	_	_
26	death	_	_	NN	_	_	_	_	_
27	incidents	_	_	NNS	_	_	_	_	_
28	.	_	_	.	_	_	_	_	_


1	However	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	main	_	_	JJ	_	_	_	_	_
5	effect	_	_	NN	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	these	_	_	DT	_	_	_	_	_
8	measures	_	_	NNS	_	_	_	_	_
9	being	_	_	VBG	_	_	_	_	_
10	a	_	_	DT	_	_	_	_	_
11	decrease	_	_	NN	_	_	_	_	_
12	in	_	_	IN	_	_	_	_	_
13	spreading	_	_	NN	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	parasite	_	_	NN	_	_	_	_	_
17	and	_	_	CC	_	_	_	_	_
18	not	_	_	RB	_	_	_	_	_
19	in	_	_	IN	_	_	_	_	_
20	decrease	_	_	NN	_	_	_	_	_
21	of	_	_	IN	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	death	_	_	NN	_	_	_	_	_
24	rate	_	_	NN	_	_	_	_	_
25	,	_	_	,	_	_	_	_	_
26	the	_	_	DT	_	_	_	_	_
27	researchers	_	_	NNS	_	_	_	_	_
28	decided	_	_	VBD	_	_	_	_	_
29	to	_	_	TO	_	_	_	_	_
30	tackle	_	_	VB	_	_	_	_	_
31	the	_	_	DT	_	_	_	_	_
32	puzzle	_	_	NN	_	_	_	_	_
33	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	scientists	_	_	NNS	_	_	_	_	_
3	studied	_	_	VBD	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	molecules	_	_	NNS	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	human	_	_	JJ	_	_	_	_	_
8	immune	_	_	JJ	_	_	_	_	_
9	system	_	_	NN	_	_	_	_	_
10	activates	_	_	VBZ	_	_	_	_	_
11	in	_	_	IN	_	_	_	_	_
12	response	_	_	NN	_	_	_	_	_
13	to	_	_	TO	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	attack	_	_	NN	_	_	_	_	_
16	.	_	_	.	_	_	_	_	_


1	They	_	_	PRP	_	_	_	_	_
2	were	_	_	VBD	_	_	_	_	_
3	looking	_	_	VBG	_	_	_	_	_
4	for	_	_	IN	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	way	_	_	NN	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	parasites	_	_	NNS	_	_	_	_	_
9	inhibit	_	_	VBP	_	_	_	_	_
10	it	_	_	PRP	_	_	_	_	_
11	and	_	_	CC	_	_	_	_	_
12	lead	_	_	VB	_	_	_	_	_
13	to	_	_	TO	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	death	_	_	NN	_	_	_	_	_
16	of	_	_	IN	_	_	_	_	_
17	the	_	_	DT	_	_	_	_	_
18	victim	_	_	NN	_	_	_	_	_
19	.	_	_	.	_	_	_	_	_


1	Of	_	_	IN	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	several	_	_	JJ	_	_	_	_	_
4	known	_	_	VBN	_	_	_	_	_
5	parasite	_	_	NN	_	_	_	_	_
6	species	_	_	NNS	_	_	_	_	_
7	,	_	_	,	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	two	_	_	CD	_	_	_	_	_
10	that	_	_	WDT	_	_	_	_	_
11	can	_	_	MD	_	_	_	_	_
12	infect	_	_	VB	_	_	_	_	_
13	humans	_	_	NNS	_	_	_	_	_
14	were	_	_	VBD	_	_	_	_	_
15	chosen	_	_	VBN	_	_	_	_	_
16	to	_	_	TO	_	_	_	_	_
17	study	_	_	VB	_	_	_	_	_
18	,	_	_	,	_	_	_	_	_
19	called	_	_	VBN	_	_	_	_	_
20	Trypanosoma	_	_	NNP	_	_	_	_	_
21	brucei	_	_	FW	_	_	_	_	_
22	gambiense	_	_	NN	_	_	_	_	_
23	and	_	_	CC	_	_	_	_	_
24	Trypanosoma	_	_	NNP	_	_	_	_	_
25	brucei	_	_	FW	_	_	_	_	_
26	rhodensiense	_	_	FW	_	_	_	_	_
27	.	_	_	.	_	_	_	_	_


1	Several	_	_	JJ	_	_	_	_	_
2	others	_	_	NNS	_	_	_	_	_
3	also	_	_	RB	_	_	_	_	_
4	exist	_	_	VBP	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	but	_	_	CC	_	_	_	_	_
7	they	_	_	PRP	_	_	_	_	_
8	affect	_	_	VBP	_	_	_	_	_
9	only	_	_	JJ	_	_	_	_	_
10	animals	_	_	NNS	_	_	_	_	_
11	.	_	_	.	_	_	_	_	_


1	Researchers	_	_	NNS	_	_	_	_	_
2	knew	_	_	VBD	_	_	_	_	_
3	that	_	_	IN	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	Trypanosoma	_	_	NN	_	_	_	_	_
6	attacks	_	_	NNS	_	_	_	_	_
7	typically	_	_	RB	_	_	_	_	_
8	are	_	_	VBP	_	_	_	_	_
9	repelled	_	_	VBN	_	_	_	_	_
10	by	_	_	IN	_	_	_	_	_
11	an	_	_	DT	_	_	_	_	_
12	HDL	_	_	NN	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	more	_	_	RBR	_	_	_	_	_
15	specifically	_	_	RB	_	_	_	_	_
16	trypanosome	_	_	NN	_	_	_	_	_
17	lytic	_	_	JJ	_	_	_	_	_
18	factor-1	_	_	NN	_	_	_	_	_
19	(	_	_	-LRB-	_	_	_	_	_
20	TLF-1	_	_	NN	_	_	_	_	_
21	)	_	_	-RRB-	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	It	_	_	PRP	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	generated	_	_	VBN	_	_	_	_	_
4	in	_	_	IN	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	humans	_	_	NNS	_	_	_	_	_
7	'	_	_	POS	_	_	_	_	_
8	immune	_	_	JJ	_	_	_	_	_
9	system	_	_	NN	_	_	_	_	_
10	and	_	_	CC	_	_	_	_	_
11	is	_	_	VBZ	_	_	_	_	_
12	toxic	_	_	JJ	_	_	_	_	_
13	to	_	_	TO	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	parasites	_	_	NNS	_	_	_	_	_
16	but	_	_	CC	_	_	_	_	_
17	not	_	_	RB	_	_	_	_	_
18	to	_	_	TO	_	_	_	_	_
19	humans	_	_	NNS	_	_	_	_	_
20	.	_	_	.	_	_	_	_	_


1	It	_	_	PRP	_	_	_	_	_
2	was	_	_	VBD	_	_	_	_	_
3	known	_	_	VBN	_	_	_	_	_
4	that	_	_	IN	_	_	_	_	_
5	one	_	_	CD	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	parasites	_	_	NNS	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	T.	_	_	FW	_	_	_	_	_
11	b.	_	_	FW	_	_	_	_	_
12	rhodensiense	_	_	FW	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	has	_	_	VBZ	_	_	_	_	_
15	evolved	_	_	VBN	_	_	_	_	_
16	an	_	_	DT	_	_	_	_	_
17	inhibitor	_	_	NN	_	_	_	_	_
18	of	_	_	IN	_	_	_	_	_
19	the	_	_	DT	_	_	_	_	_
20	toxic	_	_	JJ	_	_	_	_	_
21	chemical	_	_	NN	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	called	_	_	VBN	_	_	_	_	_
24	Serum	_	_	NNP	_	_	_	_	_
25	Resistance	_	_	NNP	_	_	_	_	_
26	Associated	_	_	NNP	_	_	_	_	_
27	(	_	_	-LRB-	_	_	_	_	_
28	SRA	_	_	NNP	_	_	_	_	_
29	)	_	_	-RRB-	_	_	_	_	_
30	protein	_	_	NN	_	_	_	_	_
31	.	_	_	.	_	_	_	_	_


1	However	_	_	RB	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	other	_	_	JJ	_	_	_	_	_
4	one	_	_	CD	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	T.	_	_	NNP	_	_	_	_	_
7	b.	_	_	NNP	_	_	_	_	_
8	gambiense	_	_	NN	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	was	_	_	VBD	_	_	_	_	_
11	responsible	_	_	JJ	_	_	_	_	_
12	for	_	_	IN	_	_	_	_	_
13	over	_	_	IN	_	_	_	_	_
14	95	_	_	CD	_	_	_	_	_
15	%	_	_	NN	_	_	_	_	_
16	of	_	_	IN	_	_	_	_	_
17	human	_	_	JJ	_	_	_	_	_
18	deaths	_	_	NNS	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	and	_	_	CC	_	_	_	_	_
21	it	_	_	PRP	_	_	_	_	_
22	had	_	_	VBD	_	_	_	_	_
23	been	_	_	VBN	_	_	_	_	_
24	previously	_	_	RB	_	_	_	_	_
25	unknown	_	_	JJ	_	_	_	_	_
26	why	_	_	WRB	_	_	_	_	_
27	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	study	_	_	NN	_	_	_	_	_
3	showed	_	_	VBD	_	_	_	_	_
4	that	_	_	IN	_	_	_	_	_
5	a	_	_	DT	_	_	_	_	_
6	gene	_	_	NN	_	_	_	_	_
7	mutation	_	_	NN	_	_	_	_	_
8	has	_	_	VBZ	_	_	_	_	_
9	lead	_	_	VBN	_	_	_	_	_
10	to	_	_	TO	_	_	_	_	_
11	a	_	_	DT	_	_	_	_	_
12	change	_	_	NN	_	_	_	_	_
13	in	_	_	IN	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	parasite	_	_	NN	_	_	_	_	_
16	's	_	_	POS	_	_	_	_	_
17	surface	_	_	NN	_	_	_	_	_
18	protein	_	_	NN	_	_	_	_	_
19	receptor	_	_	NN	_	_	_	_	_
20	.	_	_	.	_	_	_	_	_


1	It	_	_	PRP	_	_	_	_	_
2	does	_	_	VBZ	_	_	_	_	_
3	n't	_	_	RB	_	_	_	_	_
4	bind	_	_	VB	_	_	_	_	_
5	to	_	_	TO	_	_	_	_	_
6	TLF-1	_	_	NNP	_	_	_	_	_
7	as	_	_	RB	_	_	_	_	_
8	well	_	_	RB	_	_	_	_	_
9	as	_	_	IN	_	_	_	_	_
10	for	_	_	IN	_	_	_	_	_
11	other	_	_	JJ	_	_	_	_	_
12	species	_	_	NNS	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	leading	_	_	VBG	_	_	_	_	_
15	to	_	_	TO	_	_	_	_	_
16	a	_	_	DT	_	_	_	_	_
17	substantial	_	_	JJ	_	_	_	_	_
18	decrease	_	_	NN	_	_	_	_	_
19	in	_	_	IN	_	_	_	_	_
20	TLF-1	_	_	NNP	_	_	_	_	_
21	uptake	_	_	NN	_	_	_	_	_
22	by	_	_	IN	_	_	_	_	_
23	the	_	_	DT	_	_	_	_	_
24	parasite	_	_	NN	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	receptor	_	_	NN	_	_	_	_	_
3	is	_	_	VBZ	_	_	_	_	_
4	more	_	_	RBR	_	_	_	_	_
5	strict	_	_	JJ	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	causing	_	_	VBG	_	_	_	_	_
8	a	_	_	DT	_	_	_	_	_
9	lower	_	_	JJR	_	_	_	_	_
10	nutrient	_	_	NN	_	_	_	_	_
11	intake	_	_	NN	_	_	_	_	_
12	as	_	_	RB	_	_	_	_	_
13	well	_	_	RB	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	but	_	_	CC	_	_	_	_	_
16	it	_	_	PRP	_	_	_	_	_
17	suffices	_	_	VBZ	_	_	_	_	_
18	,	_	_	,	_	_	_	_	_
19	and	_	_	CC	_	_	_	_	_
20	the	_	_	DT	_	_	_	_	_
21	parasite	_	_	NN	_	_	_	_	_
22	defends	_	_	VBZ	_	_	_	_	_
23	against	_	_	IN	_	_	_	_	_
24	the	_	_	DT	_	_	_	_	_
25	human	_	_	JJ	_	_	_	_	_
26	immune	_	_	JJ	_	_	_	_	_
27	system	_	_	NN	_	_	_	_	_
28	.	_	_	.	_	_	_	_	_


1	As	_	_	IN	_	_	_	_	_
2	professor	_	_	NN	_	_	_	_	_
3	and	_	_	CC	_	_	_	_	_
4	head	_	_	NN	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	department	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	biochemistry	_	_	NN	_	_	_	_	_
10	and	_	_	CC	_	_	_	_	_
11	molecular	_	_	JJ	_	_	_	_	_
12	biology	_	_	NN	_	_	_	_	_
13	at	_	_	IN	_	_	_	_	_
14	UGA	_	_	NNP	_	_	_	_	_
15	(	_	_	-LRB-	_	_	_	_	_
16	and	_	_	CC	_	_	_	_	_
17	one	_	_	CD	_	_	_	_	_
18	of	_	_	IN	_	_	_	_	_
19	the	_	_	DT	_	_	_	_	_
20	leaders	_	_	NNS	_	_	_	_	_
21	of	_	_	IN	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	research	_	_	NN	_	_	_	_	_
24	)	_	_	-RRB-	_	_	_	_	_
25	Stephen	_	_	NNP	_	_	_	_	_
26	Hajduk	_	_	NNP	_	_	_	_	_
27	explained	_	_	VBD	_	_	_	_	_
28	,	_	_	,	_	_	_	_	_
29	"	_	_	``	_	_	_	_	_
30	Humans	_	_	NNS	_	_	_	_	_
31	have	_	_	VBP	_	_	_	_	_
32	evolved	_	_	VBN	_	_	_	_	_
33	TLF-1	_	_	NNP	_	_	_	_	_
34	as	_	_	IN	_	_	_	_	_
35	a	_	_	DT	_	_	_	_	_
36	highly	_	_	RB	_	_	_	_	_
37	specific	_	_	JJ	_	_	_	_	_
38	toxin	_	_	NN	_	_	_	_	_
39	against	_	_	IN	_	_	_	_	_
40	African	_	_	JJ	_	_	_	_	_
41	trypanosomes	_	_	NNS	_	_	_	_	_
42	by	_	_	IN	_	_	_	_	_
43	tricking	_	_	VBG	_	_	_	_	_
44	the	_	_	DT	_	_	_	_	_
45	parasite	_	_	NN	_	_	_	_	_
46	into	_	_	IN	_	_	_	_	_
47	taking	_	_	VBG	_	_	_	_	_
48	up	_	_	RP	_	_	_	_	_
49	this	_	_	DT	_	_	_	_	_
50	HDL	_	_	NN	_	_	_	_	_
51	because	_	_	IN	_	_	_	_	_
52	it	_	_	PRP	_	_	_	_	_
53	resembles	_	_	VBZ	_	_	_	_	_
54	a	_	_	DT	_	_	_	_	_
55	nutrient	_	_	NN	_	_	_	_	_
56	the	_	_	DT	_	_	_	_	_
57	parasite	_	_	NN	_	_	_	_	_
58	needs	_	_	VBZ	_	_	_	_	_
59	for	_	_	IN	_	_	_	_	_
60	survival	_	_	NN	_	_	_	_	_
61	.	_	_	.	_	_	_	_	_


1	But	_	_	CC	_	_	_	_	_
2	T.	_	_	NNP	_	_	_	_	_
3	b.	_	_	NNP	_	_	_	_	_
4	gambiense	_	_	NN	_	_	_	_	_
5	has	_	_	VBZ	_	_	_	_	_
6	evolved	_	_	VBN	_	_	_	_	_
7	a	_	_	DT	_	_	_	_	_
8	counter	_	_	NN	_	_	_	_	_
9	measure	_	_	NN	_	_	_	_	_
10	to	_	_	TO	_	_	_	_	_
11	these	_	_	DT	_	_	_	_	_
12	human	_	_	JJ	_	_	_	_	_
13	'	_	_	``	_	_	_	_	_
14	Trojan	_	_	JJ	_	_	_	_	_
15	horses	_	_	NNS	_	_	_	_	_
16	'	_	_	''	_	_	_	_	_
17	simply	_	_	RB	_	_	_	_	_
18	by	_	_	IN	_	_	_	_	_
19	barring	_	_	VBG	_	_	_	_	_
20	the	_	_	DT	_	_	_	_	_
21	door	_	_	NN	_	_	_	_	_
22	and	_	_	CC	_	_	_	_	_
23	not	_	_	RB	_	_	_	_	_
24	allowing	_	_	VBG	_	_	_	_	_
25	TLF-1	_	_	NNP	_	_	_	_	_
26	to	_	_	TO	_	_	_	_	_
27	enter	_	_	VB	_	_	_	_	_
28	the	_	_	DT	_	_	_	_	_
29	cell	_	_	NN	_	_	_	_	_
30	,	_	_	,	_	_	_	_	_
31	effectively	_	_	RB	_	_	_	_	_
32	blocking	_	_	VBG	_	_	_	_	_
33	human	_	_	JJ	_	_	_	_	_
34	innate	_	_	JJ	_	_	_	_	_
35	immunity	_	_	NN	_	_	_	_	_
36	and	_	_	CC	_	_	_	_	_
37	leading	_	_	VBG	_	_	_	_	_
38	to	_	_	TO	_	_	_	_	_
39	infection	_	_	NN	_	_	_	_	_
40	and	_	_	CC	_	_	_	_	_
41	ultimately	_	_	RB	_	_	_	_	_
42	disease	_	_	NN	_	_	_	_	_
43	.	_	_	.	_	_	_	_	_


1	"	_	_	``	_	_	_	_	_


1	Based	_	_	VBN	_	_	_	_	_
2	on	_	_	IN	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	results	_	_	NNS	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	research	_	_	NN	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	humans	_	_	NNS	_	_	_	_	_
10	could	_	_	MD	_	_	_	_	_
11	possibly	_	_	RB	_	_	_	_	_
12	develop	_	_	VB	_	_	_	_	_
13	a	_	_	DT	_	_	_	_	_
14	defense	_	_	NN	_	_	_	_	_
15	mechanism	_	_	NN	_	_	_	_	_
16	to	_	_	TO	_	_	_	_	_
17	keep	_	_	VB	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	parasites	_	_	NNS	_	_	_	_	_
20	from	_	_	IN	_	_	_	_	_
21	evading	_	_	VBG	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	human	_	_	JJ	_	_	_	_	_
24	defense	_	_	NN	_	_	_	_	_
25	system	_	_	NN	_	_	_	_	_
26	.	_	_	.	_	_	_	_	_


1	Stephen	_	_	NNP	_	_	_	_	_
2	Hajduk	_	_	NNP	_	_	_	_	_
3	commented	_	_	VBD	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	"	_	_	``	_	_	_	_	_
6	We	_	_	PRP	_	_	_	_	_
7	believe	_	_	VBP	_	_	_	_	_
8	this	_	_	DT	_	_	_	_	_
9	research	_	_	NN	_	_	_	_	_
10	represents	_	_	VBZ	_	_	_	_	_
11	a	_	_	DT	_	_	_	_	_
12	paradigm	_	_	NN	_	_	_	_	_
13	shift	_	_	NN	_	_	_	_	_
14	and	_	_	CC	_	_	_	_	_
15	causes	_	_	VBZ	_	_	_	_	_
16	us	_	_	PRP	_	_	_	_	_
17	to	_	_	TO	_	_	_	_	_
18	think	_	_	VB	_	_	_	_	_
19	more	_	_	RBR	_	_	_	_	_
20	broadly	_	_	RB	_	_	_	_	_
21	about	_	_	IN	_	_	_	_	_
22	how	_	_	WRB	_	_	_	_	_
23	pathogens	_	_	NNS	_	_	_	_	_
24	avoid	_	_	VBP	_	_	_	_	_
25	host	_	_	NN	_	_	_	_	_
26	defense	_	_	NN	_	_	_	_	_
27	mechanisms	_	_	NNS	_	_	_	_	_
28	.	_	_	.	_	_	_	_	_


1	It	_	_	PRP	_	_	_	_	_
2	turns	_	_	VBZ	_	_	_	_	_
3	out	_	_	RP	_	_	_	_	_
4	that	_	_	IN	_	_	_	_	_
5	African	_	_	JJ	_	_	_	_	_
6	trypanosomes	_	_	NNS	_	_	_	_	_
7	have	_	_	VBP	_	_	_	_	_
8	evolved	_	_	VBN	_	_	_	_	_
9	a	_	_	DT	_	_	_	_	_
10	diversity	_	_	NN	_	_	_	_	_
11	of	_	_	IN	_	_	_	_	_
12	ways	_	_	NNS	_	_	_	_	_
13	to	_	_	TO	_	_	_	_	_
14	avoid	_	_	VB	_	_	_	_	_
15	human	_	_	JJ	_	_	_	_	_
16	innate	_	_	JJ	_	_	_	_	_
17	and	_	_	CC	_	_	_	_	_
18	acquired	_	_	VBN	_	_	_	_	_
19	immune	_	_	JJ	_	_	_	_	_
20	systems	_	_	NNS	_	_	_	_	_
21	.	_	_	.	_	_	_	_	_


1	"	_	_	``	_	_	_	_	_

